It's Where It's at, Not How Much pp. 192-9
The end distribution of accumulated fat is important when assessing the risk of metabolic disorders. If there was a choice on where to pile on the pounds, storing it peripherally is your best option. Storing it viscerally, however, is bad news. In this review, Foster and Pagliassotti summarize how obesity-induced metabolic disorders relate to the location of fat deposition and to the inherent qualities of adipocytes.
Myonectin as a Tissue Cross-Talk Mediator pp. 200-2
Maintaining energy homeostasis is diverse and complex. Throwing skeletal muscle into the equation doesn't simplify the matter any, but it may add valuable insights into some of the networks underlying energy homeostasis. In this mini-review, Seldin and Wong look at skeletal muscle secretions, myokines, which can regulate metabolic and inflammatory responses in a para, auto and/or endocrine manner. The authors specifically focus on myonectin, a myokine they recently identified as a unifier of metabolic processes in tissues such as adipose and liver tissue, as well as promoting free fatty acid uptake into cells. Understanding the mechanisms of myonectins should help to unlock the secrets behind myokine-regulated metabolic circuits that govern energy homeostasis and can lead to metabolic disease. 
Is

Pin-Pointing Bone Marrow Progenitor-Derived Adipocytes pp. 215-29
Adipocytes have different phenotypes depending on where they are located in the body. This means that they also have different impacts on health. For instance, visceral adipocytes produce higher amounts of inflammatory molecules and less adiponectin and leptin than adipocytes found in subcutaneous areas. This leaves visceral adipocytes more vulnerable to inflammation and becoming insulin resistant, both hallmarks of obesity. Fate mapping studies are important in order to figure out where these distinct adipocyte populations are originating. In this research paper, Majka et al. use new models and methods to refine and confirm their previous reports on the identification of a subpopulation of adipocytes arising from bone marrow (Fig. 1) .
Finding the Maker's Mark pp. 230-6
Targeting adipocyte tissue plasticity, perhaps by increasing anabolic or catabolic functions, could be yet another way to combat obesity-related disease. In general, adipose remodeling is poorly understood; however, progenitor cells have been identified within adipose that are most likely involved in plasticity. Exploiting these cells may lead to potential therapies; however, they first need to be identified, a tricky process as it turns out. In this brief report, Lee and Granneman discuss a surface marker, platelet-derived growth factor receptor a (PDGFRa), which identifies cells able to differentiate into both brown and white adipocytes. The authors describe and speculate on the functional roles of these specific progenitor cells and discuss possible therapeutic directions and strategies (Fig. 2) .
Proliferation Strategy is Breed-Dependent pp. 237-41
Until recently, it was thought that once an adipocyte matured, it was then unable to dedifferentiate into a proliferative state. However, studies have shown that mature adipocytes do have the ability to dedifferentiate into proliferative-competent progeny cells in vitro. Interestingly, in cattle not all strains accomplish this in the same way. In this brief report, Wei et al. find an exception to the normal way that cattle adipocytes dedifferentiate and divide. The authors discover that angus-derived adipocytes divide in manner similar to swine tissue, extruding lipids before division, unlike most other bovine breeds. This work opens up an avenue for the study of lipid metabolism and adipogenesis by studying specific breeds.
Heavy Hydrogen Sheds Some Light on Adipocyte's Life Cycle pp. 242-5
Increasing adipose tissue mass is dependent on the life cycle of the adipocyte: birth, growth and death. Too many of these cycles, however, can lead to many detrimental effects, such as insulin resistance and fat accumulation. It is important to understand the mechanisms behind this life cycle in order to prevent the harm associated with it. White and Tchoukalova discuss a refined method that uses the incorporation of deuterium into adipocyte DNA to study adipogenesis in vivo. The authors also discuss the implications that this method holds for the understanding of adipocyte hypertrophy and adipocyte death, additional mechanisms leading to cell turnover and adipose expansion.
Lose the Sam68 for a Lean Physique pp. 246-9
Sam68, a member of the STAR family of proteins, is involved in many processes, such as neurogenesis, spermatogenesis, and as recently discovered, adipogenesis. In this commentary, Huot and Richard review their recent findings surrounding a Sam68 knockout mouse. The authors find that Sam68 deficiency can lead to splicing abnormalities and reduction of mammalian target of rapamycin (mTOR), a gene known to prevent adipogenesis. Interestingly, this reduction leads to lean phenotype (Fig. 3) .
Type 1 Diabetes up to BAT pp. 250-5
As opposed to white adipose tissue (WAT), brown adipose tissue (BAT) can actually boost metabolism and even increase our health. In this commentary, Gunawardana reviews recent research that embryonic BAT transplants in mice can actually reverse type 1 diabetes, even without the addition of insulin. The mechanism appears to work by decreasing inflammation and increasing functionality in nearby WAT. Perhaps BAT transplants will be seen in the near future for correcting a number of metabolic related diseases. 
